Washington, D.C., October 31, 2004 – Investigators from Virco today presented data that establishes a comprehensive set of clinical cutoffs -- a newly established threshold for optimal selection and ...
COBAS TaqMan HIV-1 Test, v2.0 uses a dual-target approach to increase reliability. Roche’s COBAS® TaqMan® HIV-1 Test, v2.0, has been approved by the FDA. The test will be commercially available in the ...
NEW YORK (CBS.MW) -- Orasure Technologies climbed 6 percent in early trade after the Food and Drugs Administration approved its OraQuick Rapid HIV-1 Antibody Test for use in detecting HIV-1 antibodies ...
This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (GILD) today announced that the European Commission (EC) has granted marketing authorization for Yeytuo ® (lenacapavir)—the company’s twice ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback